Development of dyskinesias in a 5-year trial and ropinirole and L-dopa

Autor: Rascol, Olivier, Brooks, David J., Korczyn, Amos D., De Deyn, Peter P., Clarke, C. E., Lang, Anthony E., Abdalla, Mona, Harmant, J., Jacquy, J., King, D., Martin, W., Destee, A., Durif, F., Aharon-Peretz, J., Reches, A., Bergamasco, B., Bracco, F., Frattolla, L., Nordera, P., Pezzoli, G., Scarlato, G., Stocchi, F., Hovestadt, A., Abbott, R., Bakheit, M., Boddie, G., Corston, R., Hawkes, C., Kennard, C., Loizou, L., McLellan, L., Park, D., Sagar, H., Spokes, E., Ward, C., Wroe, S. V.

Publikováno v: Rascol, O, Brooks, D J, Korczyn, A D, De Deyn, P P, Clarke, C E, Lang, A E, Abdalla, M, Harmant, J, Jacquy, J, King, D, Martin, W, Destee, A, Durif, F, Aharon-Peretz, J, Reches, A, Bergamasco, B, Bracco, F, Frattolla, L, Nordera, P, Pezzoli, G, Scarlato, G, Stocchi, F, Hovestadt, A, Abbott, R, Bakheit, M, Boddie, G, Brooks, D J, Clarke, C E, Corston, R, Hawkes, C, Kennard, C, Loizou, L, McLellan, L, Park, D, Sagar, H, Spokes, E, Ward, C & Wroe, S V 2006, ' Development of dyskinesias in a 5-year trial and ropinirole and L-dopa ', Movement Disorders, vol. 21, no. 11, pp. 1844-1850 . https://doi.org/10.1002/mds.20988

A 5-year trial of ropinirole and levodopa in early Parkinson's disease showed that ropinirole is associated with reduced incidence of dyskinesias. This post hoc analysis investigated whether the dyskinesia-sparing benefit of ropinirole is lost when l

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pure_au_____::74e05698e8c7fc9a2afb0d1600bf7c4e
https://pure.au.dk/portal/da/publications/development-of-dyskinesias-in-a-5year-trial-and-ropinirole-and-ldopa(bcd9147d-ea13-4eec-a054-d418fc581dd7).html